F. Lot, . Cazeinf, M. Bruyand, J. Pillonel, C. Sommen et al., Surveillance de l'infection à VIH (dépistage et déclaration obligatoire), France: Bulletin de santé publique, pp.2010-2017

L. Pascal, P. Pugliese, P. Enel, C. Barrières, and F. Cazein, Bulletin de Veille sanitaire, p.25

, Maladies infectieuses / Rapports et synthèses / Publications et outils / Accueil [Internet, 2015.

N. Ndeikoundam, D. Viriot, C. Pioche, N. Fournet, O. Hannachi et al., , vol.32, 2003.

P. Spadianphd, HIV prevention transformed: the new prevention research agenda. The Lancet, juill, vol.16, issue.9787, pp.269-78, 2011.

E. M. Connor, R. S. Sperling, R. Gelber, P. Kiselev, G. Scott et al., Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment, N Engl J Med, vol.331, issue.18, pp.1173-80, 1994.

J. Warszawski, R. Tubiana, L. Chenadec, J. Blanche, S. Teglas et al., Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort, AIDS. janv, vol.22, issue.2, pp.289-99, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00204104

M. S. Cohen, Y. Q. Chen, M. Mccauley, T. Gamble, M. C. Hosseinipour et al., Prevention of HIV-1 infection with early antiretroviral therapy, N Engl J Med. 11 août, vol.365, issue.6, pp.493-505, 2011.

Y. Q. Chen, B. Masse, L. Wang, S. Ou, X. Li et al., Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples, Contemp Clin Trials, vol.33, issue.6, pp.1280-1286, 2012.

A. J. Rodger, V. Cambiano, T. Bruun, P. Vernazza, S. Collins et al., Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy, JAMA. 12 juill, vol.316, issue.2, pp.171-81, 2016.

A. Simon, E. Billaud, and . Éditorial, Dépistage et prévention : les défis du contrôle de l'épidémie de l'infection par le VIH en France, Bull Epidémiol Hebd, p.5945, 2017.

C. C. Tsai, K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant et al., Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science, vol.270, pp.1197-1206, 1995.

J. G. García-lerma, R. A. Otten, S. H. Qari, J. E. Cong, M. Masciotra et al., Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir, PLOS Med. 5 févr, vol.5, issue.2, p.28, 2008.

U. M. Parikh, C. Dobard, S. Sharma, M. Cong, H. Jia et al., Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine, J Virol, vol.83, issue.20, pp.10358-65, 2009.

T. N. Gengiah, P. Mc, C. Baxter, L. E. Mansoor, A. B. Kharsany et al., A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection, Expert Opin Investig Drugs. mai, vol.21, issue.5, pp.695-715, 2012.

A. Karim, Q. , A. Karim, S. S. Frohlich, J. A. Grobler et al., Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women, Science. 3 sept, vol.329, issue.5996, pp.1168-74, 2010.

R. M. Grant, J. R. Lama, P. L. Anderson, V. Mcmahan, A. Y. Liu et al., Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men, N Engl J Med, vol.363, issue.27, pp.2587-99, 2010.

S. Mccormack, D. T. Dunn, M. Desai, D. I. Dolling, M. Gafos et al., Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial, Lancet Lond Engl. 2 janv, vol.387, pp.53-60, 2016.

J. Molina, C. Capitant, B. Spire, G. Pialoux, L. Cotte et al., On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection, N Engl J Med. 3 déc, vol.373, issue.23, pp.2237-2283, 2015.
URL : https://hal.archives-ouvertes.fr/halshs-01429281

J. Molina, I. Charreau, B. Spire, L. Cotte, C. J. Capitant et al., Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study, Lancet HIV. 1 sept, vol.4, issue.9, pp.402-412, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01963237

L. Van-damme, A. Corneli, K. Ahmed, K. Agot, J. Lombaard et al., Preexposure Prophylaxis for HIV Infection among African Women, N Engl J Med. 2 août, vol.367, issue.5, pp.411-433, 2012.

J. M. Marrazzo, G. Ramjee, B. A. Richardson, K. Gomez, N. Mgodi et al., Tenofovir-based preexposure prophylaxis for HIV infection among African women, N Engl J Med. 5 févr, vol.372, issue.6, pp.509-527, 2015.

M. Desai, N. Field, R. Grant, and S. Mccormack, Recent advances in pre-exposure prophylaxis for HIV, BMJ. 11 déc, vol.359, p.5011, 2017.

K. Underhill, Study designs for identifying risk compensation behavior among users of biomedical HIV prevention technologies: Balancing methodological rigor and research ethics, Soc Sci Med, vol.94, pp.115-138, 2013.

H. Mccall, N. Adams, D. Mason, and J. Willis, What is chemsex and why does it matter?, BMJ, vol.351, p.5790, 2015.

A. Hegazi, M. Lee, W. Whittaker, S. Green, R. Simms et al., Chemsex and the city: sexualised substance use in gay bisexual and other men who have sex with men attending sexual health clinics, Int J STD AIDS. 1 mars, vol.28, issue.4, pp.362-368, 2017.

, Prise en charge médical des personnes vivant avec le VIH: actualisation 2015, prophylaxie préexposition

K. Champenois, J. Gall, C. Jacquemin, S. Jean, C. Martin et al., TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men, BMJ Open. 1 janv, vol.2, issue.2, p.693, 2012.

M. Noret, S. Balavoine, C. Pintado, M. Siguier, A. Brun et al., Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France, AIDS Lond Engl. 24 sept, vol.32, issue.15, pp.2161-2170, 2018.

, Léobon Alain. 4ème édition du Net Gay Baromètre français. Rapport de recherche relatif à l'édition française du Net Gay Baromètre 2013-2014 -Portrait des Jeunes HSH séronégatifs ou séro-interrogatifs

M. R. Beymer, J. L. Gildner, I. W. Holloway, and R. J. Landovitz, Acceptability of Injectable and On-Demand Pre-Exposure Prophylaxis Among an Online Sample of Young Men Who Have Sex with Men in California, LGBT Health. 17 août, vol.5, issue.6, pp.341-350, 2018.

E. W. Hall, W. Heneine, T. Sanchez, R. C. Sineath, and P. Sullivan, Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United States, J Med Internet Res, vol.18, issue.5, p.111, 2016.

, IAS Conference on HIV Science, issue.9, 2017.

D. H. Paris-;-tan, R. J. Fowler, S. Hart, T. Wilton, J. Bayoumi et al., Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men, 2017.

L. A. Eaton and S. C. Kalichman, Risk Compensation in HIV Prevention: Implications for Vaccines, Microbicides, and Other Biomedical HIV Prevention Technologies, Curr HIV/AIDS Rep. déc, vol.4, issue.4, pp.165-72, 2007.

L. Lal, J. Audsley, D. A. Murphy, C. K. Fairley, M. Stoove et al., Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users, AIDS. juill, vol.31, issue.12, p.1709, 2017.

M. W. Traeger, S. E. Schroeder, E. J. Wright, M. E. Hellard, V. J. Cornelisse et al., Effects of Preexposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis, Clin Infect Dis. 16 août, vol.67, issue.5, pp.676-86, 2018.

N. Kojima, D. J. Davey, and J. D. Klausner, Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men, AIDS Lond Engl, vol.10, issue.14, pp.2251-2253, 2016.

V. Nguyen, Z. R. Greenwald, H. Trottier, M. Cadieux, A. Goyette et al., Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV, AIDS Lond Engl. 20 févr, vol.32, issue.4, pp.523-553, 2018.

M. W. Traeger, V. J. Cornelisse, J. Asselin, B. Price, N. J. Roth et al., Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection, JAMA. 9 avr, vol.321, issue.14, pp.1380-90, 2019.

A. Y. Liu, S. E. Cohen, E. Vittinghoff, P. L. Anderson, S. Doblecki-lewis et al., HIV Pre-Exposure Prophylaxis Integrated with Municipal and Community Based Sexual Health Services, JAMA Intern Med. janv, vol.176, issue.1, pp.75-84, 2016.

J. L. Marcus, L. B. Hurley, C. B. Hare, D. P. Nguyen, T. Phengrasamy et al., Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation, J Acquir Immune Defic Syndr, vol.73, issue.5, pp.540-546, 1999.

M. Siguier and J. Molina, HIV preexposure prophylaxis: An essential, safe and effective prevention tool for sexual health, Médecine Mal Infect. août, vol.48, issue.5, pp.318-344, 2018.

S. M. Jenness, K. M. Weiss, S. M. Goodreau, T. Gift, H. Chesson et al., Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study, Clin Infect Dis Off Publ Infect Dis Soc Am. 1 sept, vol.65, issue.5, pp.712-720, 2017.

L. Sagaon-teyssier, M. Suzan-monti, B. Demoulin, C. Capitant, N. Lorente et al., Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial, AIDS Care, vol.28, issue.1, pp.48-55, 2016.
URL : https://hal.archives-ouvertes.fr/halshs-01562511

V. J. Cornelisse, C. K. Fairley, T. Read, D. Lee, S. Walker et al., Associations Between Anorectal Chlamydia and Oroanal Sex or Saliva Use as a Lubricant for Anal Sex: A Cross-sectional Survey, Sex Transm Dis. août, vol.45, issue.8, pp.506-516, 2018.

P. Carrillo-santisteve, L. Tavoschi, E. Severi, S. Bonfigli, M. Edelstein et al., Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review, Lancet Infect Dis, vol.17, issue.10, pp.306-325, 2017.

, Données épidémiologiques / Hépatite A / Hépatites virales / Maladies infectieuses / Dossiers thématiques / Accueil [Internet

A. Blanc, F. Bonnet, F. Brun-vezinet, D. Costagliola, F. Dabis et al., Groupe des experts « Prise en charge médicale des personnes infectées par le VIH », p.46, 2018.

C. Brouard, Connaissances, perceptions et pratiques vis-à-vis de l'hépatite B en population générale en France métropolitaine en 2010, Bull Epidémiol Hebd, p.24, 2012.

I. Holloway, R. Dougherty, J. Gildner, S. Beougher, C. Pulsipher et al., Brief Report: PrEP Uptake, Adherence, and Discontinuation Among California YMSM Using Geosocial Networking Applications, Jaids J Acquir Immune Defic Syndr. 1 janv, vol.74, issue.1, pp.15-20, 2017.

R. J. Landovitz, C. Tseng, M. Weissman, M. Haymer, B. Mendenhall et al., Sexual Risk Behavior, and HIV Prevention Practices of Men who Have Sex with Men Using GRINDR in Los Angeles, California, J Urban Health Bull N Y Acad Med. août, vol.90, issue.4, pp.729-768, 2013.

I. W. Holloway, C. A. Pulsipher, J. Gibbs, A. Barman-adhikari, and E. Rice, Network Influences on the Sexual Risk Behaviors of Gay, Bisexual and Other Men Who Have Sex With Men Using Geosocial Networking Applications, AIDS Behav. juin, vol.19, issue.2, pp.112-134, 2015.

M. R. Beymer, R. E. Weiss, R. K. Bolan, E. T. Rudy, L. B. Bourque et al., Sex On-Demand: Geosocial Networking Phone Apps and Risk of Sexually Transmitted Infections among a Cross-Sectional Sample of Men who have Sex with Men in Los Angeles County, Sex Transm Infect, vol.90, issue.7, pp.567-72, 2014.

J. J. Lehmiller and M. Ioerger, Social Networking Smartphone Applications and Sexual Health Outcomes among Men Who Have Sex with Men, PLOS ONE. 23 janv, vol.9, issue.1, p.86603, 2014.

E. Burrell, H. Pines, R. E. Colman, L. Murphy, R. Hess et al., Use of the Location-based Social Networking Application GRINDR as a Recruitment Tool in Rectal Microbicide Development Research, AIDS Behav, vol.16, issue.7, pp.1816-1836, 2012.

H. J. Rendina, R. H. Jimenez, C. Grov, A. Ventuneac, and J. T. Parsons, Patterns of Lifetime and Recent HIV Testing Among Men Who Have Sex with Men in New York City Who Use Grindr, AIDS Behav. janv, vol.18, issue.1, pp.41-50, 2014.

A. E. Grulich, R. Guy, J. Amin, J. F. Selvey, C. Holden et al., Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study, Lancet HIV. 1 nov, vol.5, issue.11, pp.629-666, 2018.

P. Pugliese and E. Cua, , vol.18, 2019.

, Materials and methods: Over a period of 26 months, we collected data from patients who initiated PrEP in 3 centers of our department. The prevalence of STIs over the two years before inclusion, and over the study period, as well as the incidence of STIs were calculated for the entire cohort, PrEP in real life: epidemiological characteristics and incidence of sexually transmitted infections Introduction: We have limited data outside clinical studies for people who started PrEP in France, p.333, 2015.

, During the follow-up, one HIV infection was diagnosed (0.39 / 100 AP) and 121 patients had at least one STI, that leads to an incidence of 66.28 / 100 AP. We didn't note a difference between the prevalence in the two years before inclusion (41%, [136/333]) and over the study period (36%, GRINDR and chemsex users

, Only middle-aged men who have sex with men seem to be aware of it. Despite the absence of an increase in the prevalence of STIs, our study confirms a high rate of STIs, particularly rectal ones. This probably reflects the decrease in condom use, and systematic screening for infections, most of them being asymptomatic. Prophylaxis should be extended to all at-risk groups and all ages through general practitioners and community structures, Conclusion: PrEP, poorly known by health workers, disrupts the prevention of HIV infection

, Serment d'Hippocrate

, Au moment d'être admis à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je donnerai mes soins à l'indigent et à quiconque me les demandera. Je ne me laisserai pas influencer

, Reçu à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses ; que je sois déshonoré et méprisé si j'y manque